Invention Grant
US08653140B2 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
有权
施用6- [3-(1-金刚烷基)-4-甲氧基苯基] -2-萘甲酸,用于治疗皮肤病
- Patent Title: Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
- Patent Title (中): 施用6- [3-(1-金刚烷基)-4-甲氧基苯基] -2-萘甲酸,用于治疗皮肤病
-
Application No.: US13475827Application Date: 2012-05-18
-
Publication No.: US08653140B2Publication Date: 2014-02-18
- Inventor: Michael Graeber , Janusz Czernielewski
- Applicant: Michael Graeber , Janusz Czernielewski
- Applicant Address: FR Biot
- Assignee: Galderma Research & Development
- Current Assignee: Galderma Research & Development
- Current Assignee Address: FR Biot
- Agency: Dentons US LLP
- Priority: FR0203070 20020312
- Main IPC: A01N37/10
- IPC: A01N37/10 ; A61K31/19 ; A01N37/00 ; A61K31/185 ; A61K8/02
![Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders](/abs-image/US/2014/02/18/US08653140B2/abs.jpg.150x150.jpg)
Abstract:
Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.
Public/Granted literature
Information query